We are live on
!
Find out more
Prime Medicine
PRME
PRME
192 hedge funds and large institutions have $343M invested in Prime Medicine in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
56% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 25
46% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 50
27% more call options, than puts
Call options by funds: $3.62M | Put options by funds: $2.86M
5% more funds holding
Funds holding: 183 → 192 (+9)
2% more capital invested
Capital invested by funds: $337M → $343M (+$5.94M)
0.84% more ownership
Funds ownership: 53.75% → 54.59% (+0.84%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
192
Holders Change
+9
Holders Change %
+4.92%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
39
Increased
73
Reduced
50
Closed
25
Calls
$3.62M
Puts
$2.86M
Net Calls
+$760K
Net Calls Change
+$1.05M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$2.99M |
| 2 |
Morgan Stanley
New York
|
-$2.02M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.95M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.91M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.75M |
